Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page displays a newer revision label (v3.6.3) replacing the prior version. This signals an update to the page's documentation or underlying UI rather than a change to the study details.SummaryDifference0.0%

- Check21 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a recent update to the page. This likely reflects maintenance or bug fixes rather than changes to the study details or results.SummaryDifference0.0%

- Check35 days agoChange DetectedEnrollment status indicates recruitment has ended. New help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header formatting was adjusted, with the revision tag updated to v3.6.0.SummaryDifference0.3%

- Check42 days agoChange DetectedThe page shows Revision: v3.5.5, replacing v3.5.4, indicating a backend or content-management update rather than a change to the study information.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision label updated to v3.5.4. This appears to be an internal site update with no visible changes to the study details.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page’s revision/version label was updated from **v3.5.2** to **v3.5.3**, reflecting a site software update rather than a change to the study information.SummaryDifference0.0%

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.